Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/728"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label |
"evidence_1416"
|
| rdf:type | |
| ?:Evidence_enzyme_system | |
| ?:Evidence_type | |
| ?:content |
"The FDA recommends S-mepheytoin to be an acceptable chemical CYP2C19 substrate (S-mephenytoin 4' hydroxylation) for in vitro experiments in it most recent guidance document. See Table 3, p. 32"
|
| dc:creator | |
| dc:date |
"06/11/2009 16:04:51"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ S-mephenytoin_in_vitro_probe_substrate_of_enzyme_cyp2c19, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1416 }